Hims & Hers Health Net Long-Term Debt 2020-2025 | HIMS
- Hims & Hers Health net long-term debt for the quarter ending March 31, 2025 was $0M, a 0% increase year-over-year.
- Hims & Hers Health net long-term debt for the twelve months ending March 31, 2025 was $0M, a 0% increase year-over-year.
- Hims & Hers Health annual net long-term debt for 2024 was $0B, a 0% decline from 2023.
- Hims & Hers Health annual net long-term debt for 2023 was $0B, a 0% decline from 2022.
- Hims & Hers Health annual net long-term debt for 2022 was $0B, a 0% decline from 2021.
Hims & Hers Health Annual Net Long-Term Debt (Millions of US $) |
|
---|---|
2024 | $N/A |
2023 | $N/A |
2022 | $N/A |
2021 | $N/A |
2020 | $-2 |
2019 | $-7 |
2018 | $N/A |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $12.000B | $1.477B |
Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree Acquisition Corp., is based in San Francisco. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Veeva Systems (VEEV) | United States | $46.136B | 58.95 |
Tempus AI (TEM) | United States | $10.868B | 0.00 |
IRhythm Technologies (IRTC) | United States | $4.592B | 0.00 |
Inspire Medical Systems (INSP) | United States | $4.068B | 63.55 |
Hinge Health (HNGE) | United States | $3.121B | 0.00 |
Privia Health (PRVA) | United States | $2.805B | 191.75 |
Enovis (ENOV) | United States | $1.818B | 10.14 |
Schrodinger (SDGR) | United States | $1.741B | 0.00 |
Clover Health Investments (CLOV) | United States | $1.567B | 0.00 |
Phreesia (PHR) | United States | $1.501B | 0.00 |
Omnicell (OMCL) | United States | $1.466B | 25.86 |
Azenta (AZTA) | United States | $1.310B | 60.89 |
10x Genomics (TXG) | United States | $1.150B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.648B | 0.00 |
Claritev (CTEV) | United States | $0.605B | 0.00 |
Butterfly Network (BFLY) | United States | $0.591B | 0.00 |
Talkspace (TALK) | United States | $0.553B | 165.25 |
Veradigm (MDRX) | United States | $0.466B | 0.00 |
Standard BioTools (LAB) | United States | $0.410B | 0.00 |
TruBridge (TBRG) | United States | $0.353B | 784.00 |
Outset Medical (OM) | United States | $0.342B | 0.00 |
Health Catalyst (HCAT) | United States | $0.275B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.263B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.200B | 0.00 |
KORU Medical Systems (KRMD) | United States | $0.130B | 0.00 |
Pulmonx (LUNG) | United States | $0.124B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.118B | 0.00 |
American Well (AMWL) | United States | $0.108B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.101B | 0.00 |
CareCloud (CCLD) | United States | $0.091B | 3.45 |
111 (YI) | China | $0.071B | 0.00 |
HeartBeam (BEAT) | United States | $0.057B | 0.00 |
P3 Health Partners (PIII) | United States | $0.047B | 0.00 |
Zepp Health (ZEPP) | Netherlands | $0.035B | 0.00 |
Zhongchao (ZCMD) | China | $0.028B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.026B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.022B | 0.00 |
Precipio (PRPO) | United States | $0.016B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
MSP Recovery (MSPR) | United States | $0.012B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
Predictive Oncology (POAI) | United States | $0.009B | 0.00 |
Movano (MOVE) | United States | $0.004B | 0.00 |
HeartSciences (HSCS) | United States | $0.004B | 0.00 |
Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
Future Health ESG (FHLT) | United States | $0.000B | 0.00 |